SAN FRANCISCO, Sept. 25, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease (“ILD”), did not meet its main goal. The development and severe market reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether aTyr may have mi ...

NEW YORK, Sept. 24, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  aTyr Pharma, Inc. (“aTyr” or the “Company”) (NASDAQ: ATYR).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether aTyr and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On September 15, 2 ...

SAN FRANCISCO, Sept. 22, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease (“ILD”), did not meet its main goal. The development and severe market reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether aTyr may have mi ...

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro.Here's the latest list of major oversold players ...

CHICAGO, Sept. 17, 2025 (GLOBE NEWSWIRE) -- The Foundation for Sarcoidosis Research (FSR) expresses both solidarity and resolve as aTyr Pharma announced that its Phase 3 trial of efzofitimod in pulmonary sarcoidosis did not meet its primary endpoint but showed several encouraging results that suggest real potential for patients living with this rare disease. While the trial (conducted in 268 patients in the U.S., Europe, Japan, and Brazil) did not achieve the primary goal of reducing oral corticosteroid use ...

SAN FRANCISCO , Sept. 17, 2025 /PRNewswire/ --Â On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease ("ILD"), did not meet its main goal. ...

SAN FRANCISCO, Sept. 16, 2025 (GLOBE NEWSWIRE) -- On September 15, 2025, investors in aTyr Pharma, Inc. (NASDAQ: ATYR) saw the price of their shares crater over 80% after the company reported that its late-stage study of efzofitimod for treating pulmonary sarcoidosis, a significant type of interstitial lung disease (“ILD”), did not meet its main goal. The development and severe market reaction has prompted national shareholders rights firm Hagens Berman to open an investigation into whether aTyr may have mi ...

美股市场表现 - 道琼斯指数上涨0.06%至45,856.77点 纳斯达克指数上涨0.75%至22,307.16点 标普500指数上涨0.37%至6,608.41点 [1] - 非必需消费品板块领涨1.9% 医疗保健板块下跌0.5% [1] 个股异动情况 - Check-Cap Ltd股价暴涨261%至2.68美元 公司与MBody AI达成最终合并协议 [9] - Helius Medical Technologies股价飙升161%至19.70美元 公司宣布启动12.5亿美元SOL支持的国库策略 并完成超额认购的PIPE发行 [9] - Robo.ai Inc股价上涨43%至2.0850美元 公司与JW Group及Ferox Investments签署合资协议 在迪拜工业城建立Robo.ai工业城 [9] - aTyr Pharma股价暴跌81%至1.1694美元 公司efzofitimod治疗肺结节病的三期研究未达到主要终点 [9] - Avidity Biosciences股价下跌7%至41.68美元 公司申请发行1500万股普通股 [9] - Hain Celestial Group股价下跌26%至1.5894美元 公司第四季度财务业绩不及预期 [9] 大宗商品表现 - 原油价格上涨1%至63.31美元 黄金价格上涨0.3%至3,698.80美元 [5] - 白银价格下跌0.1%至42.810美元 铜价上涨1%至4.6975美元 [5] 全球市场走势 - 欧洲STOXX 600指数上涨0.47% 西班牙IBEX 35指数上涨0.63% 德国DAX指数上涨0.27% 法国CAC 40指数上涨1.05% 英国富时100指数微跌0.01% [6] - 香港恒生指数上涨0.22% 中国上证综指下跌0.26% 印度BSE Sensex指数下跌0.15% [7] 经济数据 - 纽约联储制造业指数从8月的11.9降至9月的-8.7 远低于市场预期的5 [2][10]

美股市场表现 - 道琼斯指数上涨006%至4585677点 纳斯达克指数上涨075%至2230716点 标普500指数上涨037%至660841点 [1] - 非必需消费品板块上涨19% 医疗保健板块下跌05% [1] 商品市场动态 - 原油价格上涨1%至6331美元/桶 黄金价格上涨03%至369880美元/盎司 [5] - 白银下跌01%至42810美元 铜价上涨1%至46975美元 [5] 欧洲股市行情 - 欧元区STOXX 600指数上涨047% 西班牙IBEX 35指数上涨063% [6] - 德国DAX 40指数上涨027% 法国CAC 40指数上涨105% 英国富时100指数微跌001% [6] 亚太市场概况 - 香港恒生指数上涨022% 中国上证综合指数下跌026% 印度BSE Sensex指数下跌015% [7] 个股异动情况 - Check-Cap Ltd股价暴涨261%至268美元 公司与MBody AI达成最终合并协议 [9] - Helius Medical Technologies股价飙升161%至1970美元 公司启动125亿美元SOL抵押国库策略 [9] - Roboai Inc股价上涨43%至20850美元 公司与JW Group等达成迪拜工业城合资协议 [9] - aTyr Pharma股价暴跌81%至11694美元 其三期EFZO-FIT研究未达到主要终点 [9] - Avidity Biosciences股价下跌7%至4168美元 公司申请发行1500万股普通股 [9] - The Hain Celestial Group股价下跌26%至15894美元 公司第四季度业绩不及预期 [9] 经济数据表现 - 纽约联储制造业指数从8月的119降至9月的-87 远低于市场预期的5 [2][10]

PresentationIt is now my pleasure to hand the conference call over to Ashlee Dunston, aTyr's Senior Director of Investor Relations and Public Affairs. Ms. Dunston, you may begin.Good morning, ladies and gentlemen, and welcome to aTyr Pharma conference call to review the top line results for the Phase III EFZO-FIT study of efzofitimod in pulmonary sarcoidosis. [Operator Instructions] As a reminder, this conference is being recorded for replay purposes.Ashlee DunstonDirector of Investor Relations & Corporate ...